4 Ways To Level The Field Between Retail And Institutional Biotech Investors
11/4/2016 7:00:03 AM
Occasionally I like to highlight early-stage and independent work in life sciences, apart from the low-market-cap public companies in which I invest for the Life Sciences Fund. Last week I discussed several good ideas being developed in reproductive medicine and women’s health. Today I’ll look at biotechnology research.
Not all biotech entrepreneurship starts in the laboratory.
comments powered by